Classification and diagnosis of Iron overload

Haematologica

Volumn 83, Issue 5, 1998, Pages 447-455

  Piperno, Alberto ^a,b  

^a SAN GERARDO HOSPITAL   (Italy)

^b Istituto di Scienze Biomediche S Gerardo   (Italy)

Author keywords

Iron overload

Indexed keywords

FERRITIN; IRON; TRANSFERRIN;

CLINICAL FEATURE; FERRITIN BLOOD LEVEL; GAUCHER DISEASE; HEMOLYTIC ANEMIA; HUMAN; IRON ABSORPTION; IRON KINETICS; IRON OVERLOAD; IRON STORAGE; LIVER BIOPSY; LIVER DISEASE; REVIEW; TRANSFUSION;

DRUG ADMINISTRATION ROUTES; FEMALE; HEMOCHROMATOSIS; HUMANS; IRON OVERLOAD; MATERNAL-FETAL EXCHANGE; PREGNANCY;

EID: 0031836302     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Finch C, Huebers H. Perspectives in iron metabolism. N Engl J Med 1982; 306:1520-8.
2. Halliday J, Powell L. Iron overload. Semin Hematol 1982; 19:42-53.
3. Pollycove M. Iron overload syndromes. Clin Physiol Biochem 1985; 4:61-77.
4. Powell L, Jazwinska E, Halliday J. Primary iron overload. In: Brock, Halliday, Pippard and Powell, eds. Iron metabolism in health and disease. London: Saunders, 1994. p. 227-70.
5. Feder J, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genet 1996; 13:399-408.
6. Camaschella C, Roetto A, Ciciliano M, et al. Juvenile and adult hemochromatosis are distinct genetic disorders. Eur J Hum Genet 1997; 5:371-5.
7. Pootrakul P, Kitcharoen K, Yansukon P, et al. The effect of erythroid hyperplasia on iron balance. Blood 1988; 71:1124-9.
8. Fargion S, Piperno A, Panajotopoulos N, Taddei M, Fiorelli G. Iron overload in subjects with beta-thalassemia trait: role of the hemochromatosis gene. Br J Haematol 1985; 61:487-90.
9. Fargion S, Cappellini M, Piperno A, Panajotopoulos N, Ronchi G, Fiorelli G. Association of hereditary spherocytosis and idiopathic hemochromatosis. A sinergistic effect in determining iron overload. Am J Clin Pathol 1986; 86:645-9.
10. Stewart G, Amess J, Eber S, et al. Thrombo-embolic disease after splenectomy for hereditary stomatocytosis. Br J Haematol 1996; 93:303-10.
11. Zanella A, Berzuini A, Colombo M, et al. Iron status in red cell pyruvate kinase deficiency: study of Italian cases. Br J Haematol 1993; 83:485-90.
12. Piperno A, Taddei M, Petrella G, Fiorelli G. Iron overload in hereditary spherocytosis. Haematologica 1984; 69:90-1.
13. Parkin J, Rush B, Degroot R, Budd R. Iron absorption after splenectomy in hereditary spherocytosis. Aust NZ J Med 1974; 4:58-61.
14. Bacon B. Causes of iron overload. N Engl J Med 1992; 326:126-7.
15. Baer D. Hereditary iron overload in African Americans. Am J Med 1996; 100:5-8.
16. Gordeuk V, Mukiibi J, Hasstedt S, et al. Iron overload in Africa. Interaction between a gene and dietary iron content. N Engl J Med 1992; 326:95-100.
17. Bonkovsky H, Banner B, Lambrecht R, Rubin R. Iron in liver diseases other than hemochromatosis. Semin Liver Dis 1996; 16:65-82.
18. Chapman R, Hussain M, Gorman A, et al. Effect of ascorbic acid deficiency on serum ferritin concentration in patients with β-thalassemia major. J Clin Pathol 1982; 35:487-91.
19. Deugnier Y, Turlin B, Le Quilleuc D, et al. A reappraisal of hepatic siderosis in patients with end-stage cirrhosis: practical implications for the diagnosis of hemochromatosis. Am J Surg Pathol 1997; 21:669-75.
20. Tagliabue A, Turconi G, Allegrini M, et al. Ascorbic acid status in thalassemia major. Haematologica 1984; 69:542-8.
21. Kaplan J, Craven C, Alexander J, Kushner J, Lamb J, Bernstein S. Regulation of the distribution of tissue iron. Lessons learned from the hypotransferrinemic mouse. In: Weintraub, Edwards and Krikker, eds. Hemochromatosis. Proceedings of the First International Conference. New York: The New York Academy of Sciences, 1988. p. 124-35.
22. Cox D. Genes of the copper pathways. Am J Hum Genet 1995; 56:828-34.
23. Yoshida K, Furihata K, Takeda S, et al. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nature Genet 1995; 9:267-72.
24. Johnson BF. Hemochromatosis resulting from prolonged oral iron therapy. N Engl J Med 1968; 278: 1100-1.
25. Deiss A. Iron metabolism in reticuloendothelial cells. Semin Hematol 1983; 20:81-90.
26. Saven A, Beutler E. Iron overload after prolonged intramuscolar iron therapy. N Engl J Med 1989; 321: 331-2.
27. Knisely A. Iron and pediatric liver disease. Semin Liv Dis 1994; 14:229-35.
28. Silver M, Beverley D, Valberg L, Cutz E, Phillips J, Shaheed W. Perinatal hemochromatosis: clinical, morphologic, and quantitative iron studies. Am J Pathol 1987; 128:538-54.
29. Deugnier YM, Loreal O, Turlin B, et al. Liver pathology in genetic hemochromatosis: a review of 135 homozygous case and their bioclinical correlation. Gastroenterology 1992; 102:2050-9.
30. Piperno A, D'Alba R, Fargion S, et al. Liver iron concentration in chronic hepatitis: a study of 98 patients. Eur J Gastroenterol Hepatol 1995; 7:1203-8.
31. Huggenvik J, Craven C, Idzerda R, Bernstein S, Kaplan J, McKnight G. A splicing defect in the mouse transferrin gene leads to congenital atransferrinemia. Blood 1989; 74:482-6.
32. Adams P, Bradley C, Frei J. Hepatic iron and zinc concentrerions after portacaval shunting for nonalcoholic cirrhosis. Hepatology 1993; 19:101-5.
33. Beinker N, Voigt M, Arendse M, Smit J, Stander I, Kirsch R. Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C. J Hepatol 1996; 25:633-8.
34. Lee R, Balcerzak S, Westerman M. Gaucher's disease: a morphologic study and measurements of iron metabolism. Am J Med 1967; 42:891-8.
35. Connor J, Menzies S, St. Martin S, Mufson E. A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brain. J Neurosci Res 1992; 31:75-83.
36. Fearnley J, Stevens J, Rudge P. Superficial siderosis of the central nervous system. Brain 1995; 118:1051-66.
37. Soergel K, Sommers S. Idiopathic pulmonary hemosiderosis and related syndromes. Am J Med 1962; 32:499-511.
38. Camaschella C, Piperno A. Hereditary hemochromatosis: recent advances in molecular genetics and clinical management. Haematologica 1997; 82:77-84.
39. Beutler E. The significance of the 187G (H63D) mutation in hemochromatosis. Am J Hum Genet 1997; 61:762-4.
40. Borot N, Roth M, Malfroy L, et al. Mutations in the MHC class I-like candidate gene for hemochromatosis in French patients. Immunogenetics 1997; 45:320-4.
41. Carella M, D'Ambrosio L, Totaro A, et al. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet 1997; 60:828-32.
42. Jouanolle A, Gandon G, Jézéquel P, et al. Hemochromatosis and HLA-H. Nature Genet 1996; 24:251-2.
43. Olivieri N, Brittenham G. Iron-chelating therapy and the treatment of thalassemia. Blood 1997; 89:739-61.
44. Ponka P. Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood 1997; 89:1-25.
45. Roberts A, Whatley S, Morgan R, Worwood M, Elder G. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997; 349:321-3.
46. Sampietro M, Piperno A, Lupica L, et al. High prevalence of the Hys63Asp HFE mutation in Italian patients with porphyria cutanea tarda. Hepatology 1998; 27:181-4.
47. Ludwig J, Hashimoto E, Porayko M, Moyer T, Baldus W. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology 1997; 112:882-8.
48. Moirand R, Mortaji A, Loreal O, Paillard F, Brissot P, Deugnier Y. A new syndrome of iron overload with normal transferrin saturation. Lancet 1997; 349:95-8.
49. Dixon R, Styles P, Al-Refaie F, et al. Assessment of hepatic iron overload in thalassemic patients by magnetic resonance spectroscopy. Hepatology 1994; 19:904-9.
50. Tsung S, Rosenthal W, Milewski K. Immunological measurement of transferrin compared with chemical measurement of total iron-binding capacity. Clin Chem 1975; 21:1063-6.
51. Girelli D, Olivieri O, De Franceschi L, Corrocher R, Bergamaschi G, Cazzola M. A linkage between hereditary hyperferritinemia not related to iron overload and autosomal dominant congenital cataract. Br J Haematol 1995; 90:931-4.
52. Scheuer PJ, Williams R, Muir AR. Hepatic pathology in relatives of patients with hemochromatosis. J Pathol Bacteriol 1962; 84:53-64.
53. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical level associated with fibrosis. Hepatology 1986; 6:24-9.
54. Piperno A, Sampietro M, Pietrangelo A, et al. Heterogeneity of hemochromatosis in Italy. Gastroenterology 1998; in press.
55. Piperno A, Fargion S, D'Alba R, et al. Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection. J Hepatol 1992; 16:364-8.
56. Nelson R, Davis F, Persky V, Becker E. Risk of neoplastic and other diseases among people with heterozigosity for hereditary hemochromatosis. Cancer 1995; 76:875-9.
57. Fleming M, Trenor III C, Su M, et al. Microcytic anemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nature Genet 1997; 16:383-6.
58. Gunshin H, Mackenzie B, Berger U, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997; 388:482-8.
59. Conrad M. Excess iron and catastrophic illness. Am J Haematol 1993; 43:234-6.
60. Piperno A, Sampietro M, D'Alba R, et al. Iron stores, response to α-interferon therapy, and effects of iron depletion in chronic hepatitis C. Liver 1996; 16:248-54.